Diseases of the Cardiovascular System, Phase IIA
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
Volunteers
Health Professionals
What is the purpose of this trial?
This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).
- Trial withJohns Hopkins University
- Ages18 years and older
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Ahmed Elmashad
- Amit Mehta
- Barbara Gordon-Kundu, MD
- Caitlin Loomis, MD
- Emily J. Gilmore, MD, FNCS, FACNS
- Guido J. Falcone, MD, ScD, MPH
- Jaehan Park
- James A. Giles, MD, PhD, MPHS, MRCP
- Jennifer Ahjin Kim, MD/PhD
- Jorge Rodriguez
- Kevin Sheth, MD
- Lauren Hachmann Sansing, MD, MS, FAHA, FANA
- Mark Warman, MD, MSc, MA
- Melissa Mariscal, MD
- Morgan Lippitt Prust, MD
- N. Abimbola Sunmonu, MD/PhD
- Syed Ali
- Last Updated03/01/2024
- Study HIC#2000031665